Back
Legend Biotech 10K Form
Sell
42
LEGN
Legend Biotech
Last Price:
46.36
Seasonality Move:
19.39%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive LEGN News And Ratings
See the #1 stock for the next 7 days that we like better than LEGN
LEGN Financial Statistics
Sales & Book Value
| Annual Sales: | $285.14M |
|---|---|
| Cash Flow: | $9.27M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $6.39 |
| Price / Book: | 7.17 |
Profitability
| EPS (TTM): | -2.58000 |
|---|---|
| Net Income (TTM): | $-465.95M |
| Gross Margin: | $140.93M |
| Return on Equity: | -40.06% |
| Return on Assets: | -27.08% |
Legend Biotech Earnings Forecast
Key Legend Biotech Financial Ratios
- The Gross Profit Margin over the past 4 years for LEGN is 49.42%.
- The Selling, General & Administrative Expenses for LEGN have been equal to 70.47% of Gross Profit Margin.
- The Research & Development expenses have been 134.04% of Revenue.
- The Interest Expense is -4.21% of Operating Income.
- The Net Earning history of LEGN is -181.75% of Total Revenues.
- Per Share Earnings over the last 6 years have been positive in 1 years.
Legend Biotech Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | LEGN |
| CUSIP: | 52490G |
| Website: | legendbiotech.com |
Debt
| Debt-to-Equity Ratio: | 0.25 |
|---|---|
| Current Ratio: | 5.66 |
| Quick Ratio: | 5.53 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
LEGN Technical Analysis vs Fundamental Analysis
Sell
42
Legend Biotech (LEGN)
is a Sell
Is Legend Biotech a Buy or a Sell?
-
Legend Biotech stock is rated a Sell
The current Legend Biotech [LEGN] share price is $45.76. The Score for LEGN is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.